Arkolith/Insider Trading/MAIA/Form 4/A

Smith Stan

DirectorMAIA Biotechnology, Inc. (MAIA) · full profile →Form 4/A · filed Mar 5, 2025
Net Buying
Open-Market Buys
$75K
Open-Market Sells
$0
Net Open-Market Flow
$75K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 24, 2025Buy(P)50K$1.50$75K1.2M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 24, 2025Buy(P)50K$1.87$94K50K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001127602-25-008322) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML